Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Experimental and Therapeutic Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-0981 Online ISSN: 1792-1015
Journal Cover
October-2021 Volume 22 Issue 4

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
October-2021 Volume 22 Issue 4

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML

  • Supplementary Files
    • Supplementary_Data1.xlsx
    • Supplementary_Data2.xlsx
Article Open Access

Network pharmacology‑based prediction of the active compounds and mechanism of Buyang Huanwu Decoction for ischemic stroke

  • Authors:
    • Kai Wang
    • Lu Lei
    • Jinyi Cao
    • Yi Qiao
    • Ruimin Liang
    • Jialin Duan
    • Zhijun Feng
    • Yi Ding
    • Yang Ma
    • Zhifu Yang
    • Enhu Zhang
  • View Affiliations / Copyright

    Affiliations: Department of Pharmacy, Xijing Hospital, Fourth Military Medical University, Xi'an, Shaanxi 710032, P.R. China, College of Pharmacy, Shaanxi University of Chinese Medicine, Xianyang, Shaanxi 712046, P.R. China
    Copyright: © Wang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Article Number: 1050
    |
    Published online on: July 23, 2021
       https://doi.org/10.3892/etm.2021.10484
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Buyang Huanwu Decoction (BYHWD) is used to promote blood circulation and is widely used in Chinese clinical practice for the treatment and prevention of ischemic cerebral vascular diseases. However, the mechanism and active compounds of BYHWD used to treat ischemic stroke are not well understood. The current study aimed to identify the potential active components of BYHWD and explore its mechanism using network pharmacology and bioinformatics analyses. The compounds of BYHWD were obtained from public databases. Oral bioavailability and drug‑likeness were screened using the absorption, distribution, metabolism and excretion (ADME) criteria. Components of BYHWD, alongside the candidate targets of each component and the known therapeutic targets of ischemic stroke were collected. A network of target gene compounds and cerebral ischemia compounds was established using network pharmacology data sources. The enrichment of key targets and pathways was analyzed using STRING and DAVID databases. Moreover, three of key targets [IL6, VEGFA and hypoxia‑inducible‑factor‑1α (HIF‑1α)] were verified using western blot analysis. Network analysis determined 102 compounds in seven herbal medicines that were subjected to ADME screening. A total of 42 compounds as well as 79 genes formed the principal pathways associated with ischemic stroke. The 16 key compounds identified were baicalein, beta‑carotene, baicalin, kaempferol, luteolin, quercetin, hydroxysafflor yellow A, isorhamnetin, bifendate, formononetin, calycosin, astragaloside IV, stigmasterol, sitosterol, Z‑ligustilide, and dihydrocapsaicin. The core genes in this network were IL6, TNF, VEGFA, HIF‑1α, MAPK1, MAPK3, JUN, STAT3, IL1B and IL10. Furthermore, the TNF, IL17, apoptosis, PI3K‑Akt, toll‑like receptor, MAPK, NF‑κB and HIF‑1 signaling pathways were identified to be associated with ischemic stroke. Compared with the control group (no treatment), BYHWD significantly inhibited the expression of IL6 and increase the expression of HIF‑1α and VEGFA. Network pharmacology analyses can help to reveal close interactions between multi‑components and multi‑targets and enhance understanding of the potential effects of BYHWD on ischemic stroke.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

Figure 6

Figure 7

Figure 8

View References

1 

Del Sette M, Chiti A and Dinia L: Intraarterial treatment for acute ischemic stroke. N Engl J Med. 372(1177)2015.PubMed/NCBI View Article : Google Scholar

2 

Wang P, Shao BZ, Deng Z, Chen S, Yue Z and Miao CY: Autophagy in ischemic stroke. Prog Neurobiol. 163-164:98–117. 2018.PubMed/NCBI View Article : Google Scholar

3 

Writing Group Members. Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, Das SR, de Ferranti S, Després JP, et al: Heart disease and stroke statistics-2016 update: A report From the American Heart Association. Circulation. 133:e38–e360. 2016.PubMed/NCBI View Article : Google Scholar

4 

Hung IL, Hung YC, Wang LY, Hsu SF, Chen HJ, Tseng YJ, Kuo CE, Hu WL and Li TC: Chinese herbal products for ischemic stroke. Am J Chin Med. 43:1365–1379. 2015.PubMed/NCBI View Article : Google Scholar

5 

Li JH, Liu AJ, Li HQ, Wang Y, Shang HC and Zheng GQ: Buyang huanwu decoction for healthcare: Evidence-based theoretical interpretations of treating different diseases with the same method and target of vascularity. Evid Based Complement Alternat Med. 2014(506783)2014.PubMed/NCBI View Article : Google Scholar

6 

Huang J, Guo W, Cheung F, Tan HY, Wang N and Feng Y: Integrating network pharmacology and experimental models to investigate the efficacy of Coptidis and Scutellaria containing Huanglian Jiedu decoction on hepatocellular carcinoma. Am J Chin Med. 48:161–182. 2020.PubMed/NCBI View Article : Google Scholar

7 

Zhang J, Liu X, Wu J, Zhou W, Tian J, Guo S, Jia SS, Meng Z and Ni M: A bioinformatics investigation into the pharmacological mechanisms of the effect of the Yinchenhao decoction on hepatitis C based on network pharmacology. BMC Complement Med Ther. 20(50)2020.PubMed/NCBI View Article : Google Scholar

8 

Lee AY, Park W, Kang TW, Cha MH and Chun JM: Network pharmacology-based prediction of active compounds and molecular targets in Yijin-tang acting on hyperlipidaemia and atherosclerosis. J Ethnopharmacol. 221:151–159. 2018.PubMed/NCBI View Article : Google Scholar

9 

Li XK, Yang HJ, Xiao JC, Zhang J, Zhang J, Liu M, Zheng Y and Ma L: Network pharmacology based investigation into the bioactive compounds and molecular mechanisms of Schisandrae chinensis Fructus against drug-induced liver injury. Bioorg Chem. 96(103553)2020.PubMed/NCBI View Article : Google Scholar

10 

Xu T, Li S, Sun Y, Pi Z, Liu S, Song F and Liu Z: Systematically characterize the absorbed effective substances of Wutou Decoction and their metabolic pathways in rat plasma using UHPLC-Q-TOF-MS combined with a target network pharmacological analysis. J Pharm Biomed Anal. 141:95–107. 2017.PubMed/NCBI View Article : Google Scholar

11 

Kim SK and Lee S, Lee MK and Lee S: A systems pharmacology approach to investigate the mechanism of Oryeong-san formula for the treatment of hypertension. J Ethnopharmacol. 244(112129)2019.PubMed/NCBI View Article : Google Scholar

12 

Wang W, Liu T, Yang L, Ma Y, Dou F, Shi L, Wen A and Ding Y: Study on the multi-targets mechanism of Triphala on cardio-cerebral vascular diseases based on network pharmacology. Biomed Pharmacother. 116(108994)2019.PubMed/NCBI View Article : Google Scholar

13 

Zhang J, Liang R, Wang L and Yang B: Effects and mechanisms of Danshen-Shanzha herb-pair for atherosclerosis treatment using network pharmacology and experimental pharmacology. J Ethnopharmacol. 229:104–114. 2019.PubMed/NCBI View Article : Google Scholar

14 

Xu T, Ma C, Fan S, Deng N, Lian Y, Tan L, Du W, Zhang S, Liu S, Ren B, et al: Systematic understanding of the mechanism of baicalin against Ischemic stroke through a network pharmacology approach. Evid Based Complement Alternat Med. 2018(2582843)2018.PubMed/NCBI View Article : Google Scholar

15 

Piñero J, Bravo À, Queralt-Rosinach N, Gutiérrez-Sacristán A, Deu-Pons J, Centeno E, García-García J, Sanz F and Furlong LI: DisGeNET: A comprehensive platform integrating information on human disease-associated genes and variants. Nucleic Acids Res. 45:D833–D839. 2017.PubMed/NCBI View Article : Google Scholar

16 

Zhang J, Yang B, Wang L and Liang R: Effects and mechanisms of Danshen-Shanzha herb-pair for atherosclerosis treatment using network pharmacology and experimental pharmacology. J Ethnopharmacol. 229:104–114. 2019.PubMed/NCBI View Article : Google Scholar

17 

Rouillard A, Gundersen G, Fernandez N, Wang Z, Monteiro CD, McDermott MG and Ma'ayan A: The harmonizome: A collection of processed datasets gathered to serve and mine knowledge about genes and proteins. Database (Oxford). 2016(baw100)2016.PubMed/NCBI View Article : Google Scholar

18 

Franceschini A, Szklarczyk D, Frankild S, Kuhn M, Simonovic M, Roth A, Lin J, Minguez P, Bork P, von Mering C and Jensen LJ: STRING v9.1: Protein-protein interaction networks, with increased coverage and integration. Nucleic Acids Res. 41 (Database issue):D808–D815. 2013.PubMed/NCBI View Article : Google Scholar

19 

Qiao P, Yan H and Wang J: EGb761 protects brain microvascular Endothelial cells against oxygen-glucose deprivation-induced injury through lncRNA Rmst/miR-150 axis. Neurochem Res. 45:2398–2408. 2020.PubMed/NCBI View Article : Google Scholar

20 

Sun Y, Xu DP, Qin Z, Wang PY, Hu BH, Yu JG, Zhao Y, Cai B, Chen YL, Lu M, et al: Protective cerebrovascular effects of hydroxysafflor yellow A (HSYA) on ischemic stroke. Eur J Pharmacol. 818:604–609. 2018.PubMed/NCBI View Article : Google Scholar

21 

Yin F, Zhou H, Fang Y, Li C, He Y, Yu L, Wan H and Yang J: Astragaloside IV alleviates ischemia reperfusion-induced apoptosis by inhibiting the activation of key factors in death receptor pathway and mitochondrial pathway. J Ethnopharmacol. 248(112319)2020.PubMed/NCBI View Article : Google Scholar

22 

Fritsche KL: Linoleic acid, vegetable oils & inflammation. Mo Med. 111:41–43. 2014.PubMed/NCBI

23 

Zdunska K, Dana A, Kolodziejczak A and Rotsztejn H: Antioxidant properties of ferulic acid and its possible application. Skin Pharmacol Physiol. 31:332–336. 2018.PubMed/NCBI View Article : Google Scholar

24 

Li J, Yu J, Ma H, Yang N, Li L, Zheng DD, Wu MX, Zhao ZL and Qi HY: Intranasal pretreatment with Z-Ligustilide, the main volatile component of Rhizoma Chuanxiong, confers prophylaxis against cerebral ischemia via Nrf2 and HSP70 signaling pathways. J Agric Food Chem. 65:1533–1542. 2017.PubMed/NCBI View Article : Google Scholar

25 

Wei Y, Liu J, Zhang H, Du X, Luo Q, Sun J, Liu F, Li M, Xu F, Wei K and Dong J: Ligustrazine attenuates inflammation and the associated chemokines and receptors in ovalbumine-induced mouse asthma model. Environ Toxicol Pharmacol. 46:55–61. 2016.PubMed/NCBI View Article : Google Scholar

26 

Pandya RS, Mao L, Zhou H, Zhou S, Zeng J, Popp AJ and Wang X: Central nervous system agents for ischemic stroke: Neuroprotection mechanisms. Cent Nerv Syst Agents Med Chem. 11:81–97. 2011.PubMed/NCBI View Article : Google Scholar

27 

Zhang WW, Xu F, Wang D, Ye J and Cai SQ: Buyang Huanwu Decoction ameliorates ischemic stroke by modulating multiple targets with multiple components: In vitro evidences. Chin J Nat Med. 16:194–202. 2018.PubMed/NCBI View Article : Google Scholar

28 

Sowndhararajan K, Deepa P, Kim M, Park SJ and Kim S: Baicalein as a potent neuroprotective agent: A review. Biomed Pharmacother. 95:1021–1032. 2017.PubMed/NCBI View Article : Google Scholar

29 

Palozza P: Can beta-carotene regulate cell growth by a redox mechanism? An answer from cultured cells. Biochim Biophys Acta. 1740:215–221. 2005.PubMed/NCBI View Article : Google Scholar

30 

Shi X, Fu Y, Zhang S, Ding H and Chen J: Baicalin attenuates subarachnoid hemorrhagic brain injury by modulating blood-brain barrier disruption, Inflammation, and oxidative damage in mice. Oxid Med Cell Longev. 2017(1401790)2017.PubMed/NCBI View Article : Google Scholar

31 

Nabavi SF, Braidy N, Gortzi O, Sobarzo-Sanchez E, Daglia M, Skalicka-Woźniak K and Nabavi SM: Luteolin as an anti-inflammatory and neuroprotective agent: A brief review. Brain Res Bull. 119:1–11. 2015.PubMed/NCBI View Article : Google Scholar

32 

Barreca D, Bellocco E, D'Onofrio G, Nabavi SF, Daglia M, Rastrelli L and Nabavi SM: Neuroprotective effects of quercetin: From chemistry to medicine. CNS Neurol Disord Drug Targets. 15:964–975. 2016.PubMed/NCBI View Article : Google Scholar

33 

Yang G, Wang N, Seto SW, Chang D and Liang H: Hydroxysafflor yellow a protects brain microvascular endothelial cells against oxygen glucose deprivation/reoxygenation injury: Involvement of inhibiting autophagy via class I PI3K/Akt/mTOR signaling pathway. Brain Res Bull. 140:243–257. 2018.PubMed/NCBI View Article : Google Scholar

34 

Zhao JJ, Song JQ, Pan SY and Wang K: Treatment with isorhamnetin protects the brain against ischemic injury in mice. Neurochem Res. 41:1939–1948. 2016.PubMed/NCBI View Article : Google Scholar

35 

Guo C, Ma Y, Ma S, Mu F, Deng J, Duan J, Xiong L, Yin Y, Wang Y, Xi M and Wen A: The role of TRPC6 in the neuroprotection of calycosin against cerebral ischemic injury. Sci Rep. 7(3039)2017.PubMed/NCBI View Article : Google Scholar

36 

Janyou A, Wicha P, Jittiwat J, Suksamrarn A, Tocharus C and Tocharus J: Dihydrocapsaicin attenuates blood brain barrier and cerebral damage in focal cerebral ischemia/reperfusion via oxidative stress and inflammatory. Sci Rep. 7(10556)2017.PubMed/NCBI View Article : Google Scholar

37 

Robson-Ansley P, Cockburn E, Walshe I, Stevenson E and Nimmo M: The effect of exercise on plasma soluble IL-6 receptor concentration: A dichotomous response. Exerc Immunol Rev. 16:56–76. 2010.PubMed/NCBI

38 

Ma Y, Zechariah A, Qu Y and Hermann DM: Effects of vascular endothelial growth factor in ischemic stroke. J Neurosci Res. 90:1873–1882. 2012.PubMed/NCBI View Article : Google Scholar

39 

Ciurea AV, Palade C, Voinescu D and Nica DA: Subarachnoid hemorrhage and cerebral vasospasm - literature review. J Med Life. 6:120–125. 2013.PubMed/NCBI

40 

Guo Y: Role of HIF-1a in regulating autophagic cell survival during cerebral ischemia reperfusion in rats. Oncotarget. 8:98482–98494. 2017.PubMed/NCBI View Article : Google Scholar

41 

Chen ZZ, Gong X, Guo Q, Zhao H and Wang L: Bu Yang Huan Wu Decoction prevents reperfusion injury following ischemic stroke in rats via inhibition of HIF-1 α, VEGF and promotion β-ENaC expression. J Ethnopharmacol. 228:70–81. 2019.PubMed/NCBI View Article : Google Scholar

42 

Oliveira DMG, Aguiar LT, de Oliveira Limones MV, Gomes AG, da Silva LC, de Morais Faria CDC and Scalzo PL: Aerobic training efficacy in inflammation, neurotrophins, and function in chronic stroke persons: A randomized controlled trial protocol. J Stroke Cerebrovasc Dis. 28:418–424. 2019.PubMed/NCBI View Article : Google Scholar

43 

Nakajima M, Nito C, Sowa K, Suda S, Nishiyama Y, Nakamura-Takahashi A, Nitahara-Kasahara Y, Imagawa K, Hirato T, Ueda M, et al: Mesenchymal stem cells overexpressing interleukin-10 promote neuroprotection in experimental acute ischemic stroke. Mol Ther Methods Clin Dev. 6:102–111. 2017.PubMed/NCBI View Article : Google Scholar

44 

Singh N, Sharma G and Mishra V: Hypoxia inducible factor-1: Its potential role in cerebral ischemia. Cell Mol Neurobiol. 32:491–507. 2012.PubMed/NCBI View Article : Google Scholar

45 

Franke TF: PI3K/Akt: Getting it right matters. Oncogene. 27:6473–6488. 2008.PubMed/NCBI View Article : Google Scholar

46 

Gao X, Zhang H, Takahashi T, Hsieh J, Liao J, Steinberg GK and Zhao H: The Akt signaling pathway contributes to postconditioning's protection against stroke; the protection is associated with the MAPK and PKC pathways. J Neurochem. 105:943–955. 2008.PubMed/NCBI View Article : Google Scholar

47 

Eltzschig HK and Eckle T: Ischemia and reperfusion-from mechanism to translation. Nat Med. 17:1391–1401. 2011.PubMed/NCBI View Article : Google Scholar

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Wang K, Lei L, Cao J, Qiao Y, Liang R, Duan J, Feng Z, Ding Y, Ma Y, Yang Z, Yang Z, et al: Network pharmacology‑based prediction of the active compounds and mechanism of Buyang Huanwu Decoction for ischemic stroke. Exp Ther Med 22: 1050, 2021.
APA
Wang, K., Lei, L., Cao, J., Qiao, Y., Liang, R., Duan, J. ... Zhang, E. (2021). Network pharmacology‑based prediction of the active compounds and mechanism of Buyang Huanwu Decoction for ischemic stroke. Experimental and Therapeutic Medicine, 22, 1050. https://doi.org/10.3892/etm.2021.10484
MLA
Wang, K., Lei, L., Cao, J., Qiao, Y., Liang, R., Duan, J., Feng, Z., Ding, Y., Ma, Y., Yang, Z., Zhang, E."Network pharmacology‑based prediction of the active compounds and mechanism of Buyang Huanwu Decoction for ischemic stroke". Experimental and Therapeutic Medicine 22.4 (2021): 1050.
Chicago
Wang, K., Lei, L., Cao, J., Qiao, Y., Liang, R., Duan, J., Feng, Z., Ding, Y., Ma, Y., Yang, Z., Zhang, E."Network pharmacology‑based prediction of the active compounds and mechanism of Buyang Huanwu Decoction for ischemic stroke". Experimental and Therapeutic Medicine 22, no. 4 (2021): 1050. https://doi.org/10.3892/etm.2021.10484
Copy and paste a formatted citation
x
Spandidos Publications style
Wang K, Lei L, Cao J, Qiao Y, Liang R, Duan J, Feng Z, Ding Y, Ma Y, Yang Z, Yang Z, et al: Network pharmacology‑based prediction of the active compounds and mechanism of Buyang Huanwu Decoction for ischemic stroke. Exp Ther Med 22: 1050, 2021.
APA
Wang, K., Lei, L., Cao, J., Qiao, Y., Liang, R., Duan, J. ... Zhang, E. (2021). Network pharmacology‑based prediction of the active compounds and mechanism of Buyang Huanwu Decoction for ischemic stroke. Experimental and Therapeutic Medicine, 22, 1050. https://doi.org/10.3892/etm.2021.10484
MLA
Wang, K., Lei, L., Cao, J., Qiao, Y., Liang, R., Duan, J., Feng, Z., Ding, Y., Ma, Y., Yang, Z., Zhang, E."Network pharmacology‑based prediction of the active compounds and mechanism of Buyang Huanwu Decoction for ischemic stroke". Experimental and Therapeutic Medicine 22.4 (2021): 1050.
Chicago
Wang, K., Lei, L., Cao, J., Qiao, Y., Liang, R., Duan, J., Feng, Z., Ding, Y., Ma, Y., Yang, Z., Zhang, E."Network pharmacology‑based prediction of the active compounds and mechanism of Buyang Huanwu Decoction for ischemic stroke". Experimental and Therapeutic Medicine 22, no. 4 (2021): 1050. https://doi.org/10.3892/etm.2021.10484
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team